5wph: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 3: Line 3:
<StructureSection load='5wph' size='340' side='right'caption='[[5wph]], [[Resolution|resolution]] 2.19&Aring;' scene=''>
<StructureSection load='5wph' size='340' side='right'caption='[[5wph]], [[Resolution|resolution]] 2.19&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5wph]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Psepk Psepk]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5WPH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5WPH FirstGlance]. <br>
<table><tr><td colspan='2'>[[5wph]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Pseudomonas_putida_KT2440 Pseudomonas putida KT2440]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5WPH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5WPH FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BLJ:(2S)-2-amino-4-[hydroxy(methyl)arsoryl]butanoic+acid'>BLJ</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.19&#8491;</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PP_1924 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=160488 PSEPK])</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BLJ:(2S)-2-amino-4-[hydroxy(methyl)arsoryl]butanoic+acid'>BLJ</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5wph FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5wph OCA], [http://pdbe.org/5wph PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5wph RCSB], [http://www.ebi.ac.uk/pdbsum/5wph PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5wph ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5wph FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5wph OCA], [https://pdbe.org/5wph PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5wph RCSB], [https://www.ebi.ac.uk/pdbsum/5wph PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5wph ProSAT]</span></td></tr>
</table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/Q88LK7_PSEPK Q88LK7_PSEPK]
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich's salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits glutamine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the pervasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the alpha-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors.
Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic.,Nadar VS, Chen J, Dheeman DS, Galvan AE, Yoshinaga-Sakurai K, Kandavelu P, Sankaran B, Kuramata M, Ishikawa S, Rosen BP, Yoshinaga M Commun Biol. 2019 Apr 15;2:131. doi: 10.1038/s42003-019-0365-y. eCollection 2019. PMID:30993215<ref>PMID:30993215</ref>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 5wph" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Psepk]]
[[Category: Pseudomonas putida KT2440]]
[[Category: Dheeman, D S]]
[[Category: Dheeman DS]]
[[Category: Kandavelu, P]]
[[Category: Kandavelu P]]
[[Category: Rosen, B P]]
[[Category: Rosen BP]]
[[Category: Venkadesh, S]]
[[Category: Venkadesh S]]
[[Category: Yoshinaga, M]]
[[Category: Yoshinaga M]]
[[Category: N-acetyltransferase]]
[[Category: Pseudomonas putida]]
[[Category: Transferase]]